| Biological implications and therapeutic significance of DNA methylation regulated genes in cervical cancer S Bhat, SP Kabekkodu, A Noronha, K Satyamoorthy Biochimie 121, 298-311, 2016 | 63 | 2016 |
| SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumors L Roth, S Srivastava, M Lindzen, A Sas-Chen, M Sheffer, M Lauriola, ... Science signaling 11 (515), eaan0949, 2018 | 53 | 2018 |
| An oligoclonal antibody durably overcomes resistance of lung cancer to third‐generation EGFR inhibitors M Mancini, H Gal, N Gaborit, L Mazzeo, D Romaniello, TM Salame, ... EMBO Molecular Medicine 10 (2), 294-308, 2018 | 47 | 2018 |
| A combination of approved antibodies overcomes resistance of lung cancer to osimertinib by blocking bypass pathways D Romaniello, L Mazzeo, M Mancini, I Marrocco, A Noronha, M Kreitman, ... Clinical Cancer Research 24 (22), 5610-5621, 2018 | 44 | 2018 |
| AXL and error-prone DNA replication confer drug resistance and offer strategies to treat EGFR-mutant lung cancer A Noronha, N Belugali Nataraj, JS Lee, B Zhitomirsky, Y Oren, S Oster, ... Cancer discovery 12 (11), 2666-2683, 2022 | 41 | 2022 |
| PD-L1 recruits phospholipase C and enhances tumorigenicity of lung tumors harboring mutant forms of EGFR S Ghosh, NB Nataraj, A Noronha, S Patkar, A Sekar, S Mukherjee, ... Cell reports 35 (8), 2021 | 30 | 2021 |
| Irreversible modifications of receptor tyrosine kinases M Kreitman, A Noronha, Y Yarden FEBS letters 592 (13), 2199-2212, 2018 | 22 | 2018 |
| Nucleoporin-93 reveals a common feature of aggressive breast cancers: robust nucleocytoplasmic transport of transcription factors NB Nataraj, A Noronha, JS Lee, S Ghosh, HRM Raju, A Sekar, ... Cell reports 38 (8), 2022 | 13 | 2022 |
| Cross-talk between mutant p53 and p62/SQSTM1 augments cancer cell migration by promoting the degradation of cell adhesion proteins S Mukherjee, M Maddalena, YQ Lü, S Martinez, NB Nataraj, A Noronha, ... Proceedings of the National Academy of Sciences 119 (17), e2119644119, 2022 | 12 | 2022 |
| Time-resolved profiling reveals ATF3 as a novel mediator of endocrine resistance in breast cancer S Borgoni, E Sofyalı, M Soleimani, H Wilhelm, K Müller-Decker, R Will, ... Cancers 12 (10), 2918, 2020 | 11 | 2020 |
| Computational optimization of antibody humanness and stability by systematic energy-based ranking A Tennenhouse, L Khmelnitsky, R Khalaila, N Yeshaya, A Noronha, ... Nature biomedical engineering 8 (1), 30-44, 2024 | 9 | 2024 |
| Targeting autocrine amphiregulin robustly and reproducibly inhibits ovarian cancer in a syngeneic model: roles for wildtype p53 M Lindzen, S Ghosh, A Noronha, D Drago, NB Nataraj, O Leitner, ... Oncogene 40 (21), 3665-3679, 2021 | 9 | 2021 |
| Inhibition of a pancreatic cancer model by cooperative pairs of clinically approved and experimental antibodies R Maron, B Schechter, NB Nataraj, S Ghosh, D Romaniello, I Marrocco, ... Biochemical and biophysical research communications 513 (1), 219-225, 2019 | 9 | 2019 |
| Host-dependent phenotypic resistance to EGFR tyrosine kinase inhibitors Y Haga, I Marrocco, A Noronha, ML Uribe, NB Nataraj, A Sekar, ... Cancer research 81 (14), 3862-3875, 2021 | 4 | 2021 |
| Engineered variants of the Ras effector protein RASSF5 (NORE1A) promote anticancer activities in lung adenocarcinoma A Singh, A Erijman, A Noronha, H Kumar, Y Peleg, Y Yarden, JM Shifman Journal of Biological Chemistry 297 (6), 2021 | 3 | 2021 |
| Reliable energy-based antibody humanization and stabilization A Tennenhouse, L Khmelnitsky, R Khalaila, N Yeshaya, A Noronha, ... bioRxiv, 2022.08. 14.503891, 2022 | 2 | 2022 |
| Nucleoporin-93 overexpression overcomes multiple nucleocytoplsamic trafficking bottlenecks to permit robust metastasis N Nataraj, A Noronha, J Lee, S Ghosh, HRM Raju, A Sekar, B Zuckerman, ... | 1 | 2020 |
| Oxidative stress and therapeutic development in lung cancer A Chowdhury, S Sarkar, S Ghosh, A Noronha, T Chakraborti, ... Oxidative Stress in Lung Diseases: Volume 2, 427-443, 2020 | 1 | 2020 |
| Nucleoporin-93 Overcomes Multiple Nucleocytoplasmic Trafficking Bottlenecks and Permits Robust Metastasis A Noronha, J Sang Lee, S Ghosh, HR Mohan Raju, A Sekar, ... | | |
| PD-L1 Recruits Phospholipase C and Enhances EGFR Signaling: Relevance to Resistance of EGFR-Mutated Lung Tumors to Immunotherapy S Ghosh, A Noronha, S Patkar, A Sekar, S Mukherjee, SW Katz, ... | | |
